BioSpace News Archive

Policy

ChromaCode Launches High-Throughput HDPCR™ SARS-CoV-2 Assay

ChromaCode joining fight against novel coronavirus; High-Definition PCR SARS-CoV-2 assay to increase test throughput and reduce complexity of interpretation

April 21, 2020
·
2 min read
Bayer partners with Population Health Research Institute (PHRI) on major global research study on COVID-19 treatments

The Population Health Research Institute and Bayer Inc. announced plans to immediately launch a major clinical research program aimed at identifying potential COVID-19 treatments.

April 21, 2020
·
5 min read
Deals

ReAlta Life Sciences Closes $14 Million Series A2 Financing to Support Transition into a Clinical Organization

Proceeds to Fund Advancement of Programs Addressing Acute Lung Injury Due to COVID-19 and Severe Birth Asphyxia (HIE)

April 21, 2020
·
2 min read
Policy

Coronavirus (COVID-19) Update: FDA Authorizes First Test for Patient At-Home Sample Collection

The U.S. Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19.

April 21, 2020
·
2 min read
Business

Surmodics to Webcast Second Quarter Fiscal 2020 Earnings Conference Call on April 29

Surmodics, Inc. today announced that it will host a live webcast of its second quarter fiscal 2020 conference call on Wednesday, April 29, at 4 p.m. CT (5 p.m. ET). The Company will issue an earnings news release after the market closes that afternoon. Gar

April 21, 2020
·
1 min read
Biotech Beach

Glaukos Corporation to Release First Quarter 2020 Financial Results after Market Close on May 7

Conference Call and Webcast Scheduled for 1:30 p.m. PDT

April 21, 2020
·
1 min read
Afeka College conducts research to identify potential COVID-19 carriers using voice analysis

A groundbreaking research project led by the Israeli Ministry of Defense (MOD) is currently underway at Afeka Tel-Aviv Academic College of Engineering to detect pre-diagnostic COVID-19 potential carriers using voice and speech processing

April 21, 2020
·
2 min read
Drug Development

OncoSec Presents Pre-Clinical Data from Its Visceral Lesion Applicator (VLA) and APOLLO Feasibility Study Demonstrating TAVO™ Can Be Safely Delivered and Electroporated in Liver at the Online Society of Interventional Radiology Annual Meeting

OncoSec Medical Incorporated (“OncoSec”) (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced pre-clinical data from a feasibility study of its visceral lesion applicator (VLA) electroporation device and APOLLO generator which were presented online at the Annual Meeting of the Society of Interventional Radiology (SIR).

April 21, 2020
·
7 min read
Drug Development

twoXAR Pharmaceuticals Presents Preclinical Data Demonstrating Positive Safety and Tolerability of Two Novel Lupus Drug Leads

twoXAR Pharmaceuticals, a company that discovers drugs with AI, today announced that two novel leads for the potential treatment of systemic lupus erythematosus (SLE), TXR-711 and TXR-712, demonstrated significant efficacy and excellent tolerability in preclinical studies.

April 21, 2020
·
3 min read
Business

Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer’s Markets

Linical Company Limited (Linical) and Alpha Cognition Inc. (ACI) today announced they have signed a partnering agreement whereby Linical will provide strategic consulting services and regulatory guidance for Alpha-1062, a new chemical entity aimed to penetrate the Alzheimer’s disease market.

April 21, 2020
·
4 min read